Targeting Lcn2 is similarly not straightforward because of the multitude of cellular sources (neutrophils, adipocytes, hepatocytes, tumor cells) and receptors (Slc22a17, MC4R, megalin) (Gumpper et al, 2020). Here, LCN2 is linked to neoplasm.